https://adisinsight.springer.com/drugs/800051443?error=cookies_not_supported&code=105699dd-ccef-4f67-8e4c-7f4944c7e563
TQ B3203 - AdisInsight
Chia-tai Tianqing Pharmaceutical Group is developing TQ B3203, a camptothecin derivative for the treatment of cancer including solid tumors. Phase I development
tqadisinsight